FFCP PHASE2:Hg19::chr12:6818233..6818241,+
From FANTOM5_SSTAR
Revision as of 11:38, 24 July 2015 by Autoedit (talk | contribs) (Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=NA |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript |HGNC=NA |TSSclassifier=stron...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p@chr12:6818233..6818241, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr12:6818233..6818241, + |
Coexpression cluster: | C19_embryonic_testis_cord_chronic_CD14_NK_mesothelioma |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p@chr12:6818233..6818241+ |
---|
0
25
50
75
100
125
150
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
precursor B cell | 3.16e-08 | 3 |
hematopoietic stem cell | 5.96e-07 | 168 |
hematopoietic cell | 6.58e-07 | 177 |
hematopoietic oligopotent progenitor cell | 7.83e-07 | 161 |
hematopoietic multipotent progenitor cell | 7.83e-07 | 161 |
Showing 1 to 5 of 5 entries
Ontology term | p-value | n |
---|---|---|
hematologic cancer | 1.59e-31 | 51 |
immune system cancer | 1.59e-31 | 51 |
cancer | 2.74e-27 | 235 |
disease of cellular proliferation | 2.08e-26 | 239 |
leukemia | 1.69e-22 | 39 |
organ system cancer | 8.63e-19 | 137 |
chronic leukemia | 2.01e-16 | 8 |
myeloid leukemia | 5.55e-16 | 31 |
lymphoma | 1.20e-12 | 10 |
carcinoma | 7.01e-09 | 106 |
Showing 1 to 10 of 11 entries